How to Trip Rapid Review

Step 1: Select articles relevant to your search (remember the system is only optimised for single intervention studies)

Step 2: press

Step 3: review the result, and maybe amend the or if you know better! If we're unsure of the overall sentiment of the trial we will display the conclusion under the article title. We then require you to tell us what the correct sentiment is.

435 results for

headache

by
...
Latest & greatest
Alerts

Export results

Use check boxes to select individual results below

SmartSearch available

Trip's SmartSearch engine has discovered connected searches & results. Click to show

1. Migraine and Tension Headache

Migraine and Tension Headache ? 2018 Kaiser Foundation Health Plan of Washington. All rights reserved. 1 Migraine and Tension Headache Guideline Background 2 Diagnosis Red flag warning signs 2 Differential diagnosis 2 Imaging 3 Migraine versus tension headache 3 Medication overuse headache 3 Menstruation-related migraine 3 Tension Headache Acute treatment 4 Prophylaxis 5 Migraine Headache Acute treatment 6 Treatment of refractory migraine 7 Prophylaxis 8 Menstruation-related migraine (...) prophylaxis 11 Medication Overuse Headache Treatment 12 Evidence Summary 13 References 18 Clinician Lead and Guideline Development 21 Last guideline approval: April 2018 Guidelines are systematically developed statements to assist patients and providers in choosing appropriate health care for specific clinical conditions. While guidelines are useful aids to assist providers in determining appropriate practices for many patients with specific clinical problems or prevention issues, guidelines are not meant

2018 Kaiser Permanente Clinical Guidelines

2. Headache

Headache Date of origin: 1996 Last review date: 2013 ACR Appropriateness Criteria ® 1 Headache American College of Radiology ACR Appropriateness Criteria ® Clinical Condition: Headache Variant 1: Chronic headache. No new features. Normal neurologic examination. Radiologic Procedure Rating Comments RRL* MRI head without and with IV contrast 4 O MRI head without IV contrast 4 O CT head without IV contrast 3 ??? CT head without and with IV contrast 3 ??? CT head with IV contrast 3 ??? MRA head (...) without and with IV contrast 2 O MRA head without IV contrast 2 O Arteriography cervicocerebral 2 ??? CTA head with IV contrast 2 ??? Rating Scale: 1,2,3 Usually not appropriate; 4,5,6 May be appropriate; 7,8,9 Usually appropriate *Relative Radiation Level Variant 2: Chronic headache with new feature or neurologic deficit. Radiologic Procedure Rating Comments RRL* MRI head without and with IV contrast 8 O MRI head without IV contrast 7 O CT head without IV contrast 7 ??? CT head without and with IV

2019 American College of Radiology

3. Critical Issues in the Evaluation and Management of Adult Patients Presenting to the Emergency Department With Acute Headache

Critical Issues in the Evaluation and Management of Adult Patients Presenting to the Emergency Department With Acute Headache 1 1 2 Clinical Policy: Critical Issues in the Evaluation and Management of Adult Patients Presenting to the 3 Emergency Department With Acute Headache 4 Approved by the ACEP Board of Directors, June 26, 2019 5 6 7 From the American College of Emergency Physicians Clinical Policies Subcommittee (Writing Committee) on 8 Acute Headache: 9 10 Steven A. Godwin, MD (...) Liaison, Clinical Policies Committee and Subcommittee on Acute Headache 50 Rhonda R. Whitson, RHIA, Staff Liaison, Clinical Policies Committee 51 52 53 54 2 ABSTRACT 55 56 This clinical policy from the American College of Emergency Physicians addressed key issues in the evaluation 57 and management of adult patients presenting to the emergency department with acute headache. A writing 58 subcommittee conducted a systematic review of the literature to derive evidence-based recommendations to answer 59

2019 American College of Emergency Physicians

4. Headache ? Child

Headache ? Child Revised 2017 ACR Appropriateness Criteria ® 1 Headache–Child American College of Radiology ACR Appropriateness Criteria ® Headache–Child Variant 1: Child. Primary headache. Initial imaging. Procedure Appropriateness Category Relative Radiation Level Arteriography cerebral Usually Not Appropriate ???? CT head with IV contrast Usually Not Appropriate ??? CT head without and with IV contrast Usually Not Appropriate ???? CT head without IV contrast Usually Not Appropriate ??? CT (...) venography head with IV contrast Usually Not Appropriate ???? CTA head with IV contrast Usually Not Appropriate ???? MR venography head without IV contrast Usually Not Appropriate O MR venography head with IV contrast Usually Not Appropriate O MRA head without IV contrast Usually Not Appropriate O MRI head without and with IV contrast Usually Not Appropriate O MRI head without IV contrast Usually Not Appropriate O X-ray skull Usually Not Appropriate ?? Variant 2: Child. Secondary headache. Initial

2017 American College of Radiology

5. Botulinum neurotoxin for the treatment of blepharospasm, cervical dystonia, adult spasticity, and headache

Botulinum neurotoxin for the treatment of blepharospasm, cervical dystonia, adult spasticity, and headache Practice guideline update summary: Botulinum neurotoxin for the treatment of blepharospasm, cervical dystonia, adult spasticity, and headache | Neurology Advertisement Search for this keyword Main menu User menu Search Search for this keyword The most widely read and highly cited peer-reviewed neurology journal Share May 10, 2016 ; 86 (19) Special Article Practice guideline update summary (...) : Botulinum neurotoxin for the treatment of blepharospasm, cervical dystonia, adult spasticity, and headache Report of the Guideline Development Subcommittee of the American Academy of Neurology David M. Simpson , Mark Hallett , Eric J. Ashman , Cynthia L. Comella , Mark W. Green , Gary S. Gronseth , Melissa J. Armstrong , David Gloss , Sonja Potrebic , Joseph Jankovic , Barbara P. Karp , Markus Naumann , Yuen T. So , Stuart A. Yablon First published April 18, 2016, DOI: https://doi.org/10.1212/WNL

2016 American Academy of Neurology

6. Headache, Diagnosis and Treatment of

Headache, Diagnosis and Treatment of Headache, Diagnosis and Treatment of | ICSI The MN Health Collaborative includes physicians and other representatives from major healthcare organizations working together to address major health topics affecting Minnesota communities today. ICSI has been developing evidence-based clinical practice guidelines to improve patient care since 1993. ICSI helps forward-focused Minnesota health organizations find ways to redefine and redesign systems and the market (...) . Together, we aim to improve care and reduce costs for our patients, families and communities. e Guidelines Headache, Diagnosis and Treatment of REVISION DATE: JANUARY 2013 / ELEVENTH EDITION GUIDELINE SUMMARY Scope and Target Population Patients age 12 years and older who present with headache. For the purpose of this guideline, pain that primarily involves the back of the neck and only involves the head to a limited extent is not considered a headache. This guideline does not specifically address

2013 Institute for Clinical Systems Improvement

7. Acute and preventive pharmacologic treatment of cluster headache

Acute and preventive pharmacologic treatment of cluster headache Acute and preventive pharmacologic treatment of cluster headache | Neurology Advertisement Search for this keyword Main menu User menu Search Search for this keyword The most widely read and highly cited peer-reviewed neurology journal Share August 03, 2010 ; 75 (5) Views and Reviews Acute and preventive pharmacologic treatment of cluster headache George J. Francis , Werner J. Becker , Tamara M. Pringsheim First published August 2 (...) , 2010, DOI: https://doi.org/10.1212/WNL.0b013e3181eb58c8 George J. Francis Werner J. Becker Tamara M. Pringsheim Acute and preventive pharmacologic treatment of cluster headache George J. Francis , Werner J. Becker , Tamara M. Pringsheim Neurology Aug 2010, 75 (5) 463-473; DOI: 10.1212/WNL.0b013e3181eb58c8 Citation Manager Formats Make Comment See Comments Downloads 3092 Share This article requires a subscription to view the full text. If you have a subscription you may use the login form below

2010 American Academy of Neurology

8. Head (trauma, headaches, etc., not including stress & mental disorders).

Head (trauma, headaches, etc., not including stress & mental disorders). Guidelines and Measures | Agency for Healthcare Research & Quality HHS.gov Search ahrq.gov Search ahrq.gov Menu Topics A - Z Healthcare Delivery Latest available findings on quality of and access to health care Searchable database of AHRQ Grants, Working Papers & HHS Recovery Act Projects AHRQ Projects funded by the Patient-Centered Outcomes Research Trust Fund You are here Guidelines and Measures Funding for the National

2009 Work Loss Data Institute

9. Heart Failure - Systolic Dysfunction

. Direct acting vasodilators. Combined isosorbide dinitrate 40 mg with hydralazine 75 mg three times a day may be used as tolerated by blood pressure in symptomatic HF patients who are African American and may be used as a substitute for any HF patient who is intolerant of ACE inhibitors or ARB’s. This combination may also be used as tolerated by blood pressure in HF patients who are persistently symptomatic on ACE inhibitors, ARB’s, and/or beta blockers. Headache may develop but will often improve

2020 University of Michigan Health System

13. Insomnia

doxepin is associated with rebound insomnia and more side effects. • Headache and next-day somnolence are the most common side effects. Conclusion 12 • There is insufficient published data to support either short- or long-term use of antidepressants in the management of insomnia. • Weak evidence suggests that short-term use of low-dose doxepin may improve some objective polysomnography outcomes compared with placebo, but is associated with some adverse effects, mainly increased somnolence and rebound (...) the trial results may not be generalized to all types of shift work sleep disorders. • Low-quality evidence from one trial suggests that the hypnotic medication zopiclone did not result in significantly longer daytime sleep length compared to placebo. • Moderate-quality evidence from two trials indicating that armodafinil taken before the night shift may reduce sleepiness by one point on the Karolinska Sleepiness Scale but is associated with adverse effects, including headache and nausea. The drug

2019 Kaiser Permanente Clinical Guidelines

15. Prevention of Early-Onset Group B Streptococcal Disease in Newborns

are colonized with GBS, the potential additionalneonatalrisksassociatedwithprolongedexpec- tant management should be discussed and the reasons for discouraging such management reviewed. Consideration alsoshouldbegiventodocumentingthisdiscussioninthe Table 2. Penicillin Allergy: Low Risk or High Risk of Anaphylaxis or Severe Non-IgE Mediated Reaction Risk Definition Low Risk Nonspecific symptoms unlikely to be allergic (gastrointestinal distress, headaches, yeast vaginitis) Nonurticarial maculopapular

2020 American College of Obstetricians and Gynecologists

16. Treatment for Insomnia and Disrupted Sleep Behavior in Children and Adolescents with Autism Spectrum Disorder

that short-term melatonin use has serious AEs. 44 The most frequently reported AEs are 6 morning drowsiness, increased enuresis, headache, dizziness, diarrhea, rash, and hypothermia. 45- 7 47 Given that many children with ASD use melatonin for months/years, the lack of long-term 8 safety data is concerning. Melatonin affects the hypothalamic–gonadal axis and can potentially 9 influence pubertal development. 48 10 11 12 PRACTICE RECOMMENDATIONS 13 14 Recommendation rationales are presented; tables (...) of what was used in studies than OTC forms. Melatonin is generally administered 17 30–60 minutes before bedtime. 50 Because immediate-release melatonin has a short half-life (40 18 minutes), it is assumed that the immediate-release formulations are more helpful for sleep onset 19 insomnia and controlled-release forms more helpful for sleep maintenance. 20 21 35 No study in the SR reported serious AEs. Adverse events reported with melatonin include 1 morning drowsiness, increased enuresis, headache

2020 American Academy of Neurology

18. Head Trauma- Child

. A trial evaluating children over the age of 2 by the Pediatric Emergency Care Applied Research Network (PECARN) is the only very large, prospective study conducted exclusively in young patients. This demonstrated a 99.9% negative predictive value and a 96.8% sensitivity for clinically important injury using the criteria of normal mental status and no loss of consciousness, vomiting, severe injury mechanism, signs of basilar skull fracture, or severe headache [7]. Several other clinical algorithms (...) the importance of several clinical risk factors. There are contradictory reports concerning the probability of traumatic head injury in children with headache, vomiting, loss of consciousness, and severe mechanisms of injury [10,26,27]. Kupperman et al determined a <1% risk of significant TBI in children with these factors, although other studies have reported a higher incidence of injury [3,23,25,28]. The discrepancies are likely due to differences in the degree or duration of headache, number of emesis

2019 American College of Radiology

20. AGA Clinical Practice Guidelines on the Management of Mild-to-Moderate Ulcerative Colitis Full Text available with Trip Pro

in ulcerative colitis? evidence from cochrane reviews. Inflamm Bowel Dis . 2013 ; 19 : 2031–2040 | | Therefore, we do not recommend switching between mesalamine preparations in search of more effective treatment. Balsalazide is the preferred diazo-bonded 5-ASA due to its better tolerability. Conversely, sulfasalazine is often poorly tolerated due to side effects, such as headache, nausea, diarrhea, and rash ( Table 1 ). Patients often need to start at lower-dose sulfasalazine with gradual dose escalation

2019 American Gastroenterological Association Institute